BTA 0.00% 57.0¢ biota holdings limited

duty to release informatiom promptly

  1. 830 Posts.
    QUOTE:
    "In February 2008, the company announced its intention to commence an on market share buy back of up to 5% of the issued shares. The buy back was halted in May 2008 when the Company became aware of confidential information likely to impact the share price."

    One seriously has to question the ethics of Peter Cook and the BTA board. Dont they owe a duty to shareholders and the public to announce the suspension of the share buy back in May? Why does it take from May to end of August to make an announcement that BTA was aware of information that will impact on the share price?

    There goes Peter Cook again!!! QUOTE: "We are very pleased with AstraZeneca as licensee for our RSV program on a global basis. AstraZeneca's tremendous track record in developing and marketing small molecule therapeutics will be of great benefit in bringing RSV products to the market".
    Sound familiar? Will someone goe back and get BRA's quote on how great it is to assign the licensee the GSKfrom Glaxo Beecham!! Is history repeating itself?



 
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.